Gabapentin and Exostosis - a phase IV clinical study of FDA data
Summary:
We study 292,819 people who have side effects when taking Gabapentin. Exostosis is found, especially among people who are female, 60+ old, have been taking the drug for 5 - 10 years, also take Oxycontin and have Rheumatoid arthritis.
The phase IV clinical study analyzes which people take Gabapentin and have Exostosis. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
292,819 people reported to have side effects when taking Gabapentin.
Among them, 733 people (0.25%) have Exostosis.
What is Gabapentin?
Gabapentin has active ingredients of gabapentin. It is used in neuralgia. Currently, eHealthMe is studying from 302,044 Gabapentin users.
What is Exostosis?
Exostosis (formation of new bone on the surface of a bone) is found to be associated with 1,641 drugs and 924 conditions by eHealthMe. Currently, we are studying 12,965 people who have Exostosis.
Number of Gabapentin and Exostosis reports submitted per year:
Time on Gabapentin when people have Exostosis *:
Gender of people who have Exostosis when taking Gabapentin*:
Age of people who have Exostosis when taking Gabapentin *:
Common drugs people take besides Gabapentin *:
Common side effects people have besides Exostosis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Gabapentin and have Exostosis?
Check whether Exostosis is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
Related studies
Gabapentin side effects by duration, gender and age:
- Gabapentin side effects (302,044 reports)
Exostosis treatments and more:
- Exostosis (12,965 reports)
Common drugs associated with Exostosis:
- Fosamax: 2,493 reports
- Humira: 1,868 reports
- Methotrexate: 1,542 reports
- Zometa: 1,334 reports
- Prednisone: 1,307 reports
- Enbrel: 1,287 reports
- Aspirin: 1,108 reports
- Aredia: 807 reports
- Celebrex: 786 reports
- Gabapentin: 733 reports
All the drugs that are associated with Exostosis:
- Exostosis (1,641 drugs)
Common conditions associated with Exostosis:
- Rheumatoid arthritis: 2,387 reports
- Osteoporosis: 2,190 reports
- Pain: 931 reports
- High blood pressure: 870 reports
All the conditions that are associated with Exostosis:
- Exostosis (924 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on gabapentin (the active ingredients of Gabapentin) and Gabapentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Finasteride and Body Fat Disorder - 9 seconds ago
- Flagyl and Topamax drug interaction - 26 seconds ago
- Mucinex and Sciatica - 27 seconds ago
- Actemra and Pancreatitis - 32 seconds ago
- Mycophenolate Mofetil and Cannabis drug interaction - 32 seconds ago
- Maxalt and Nizoral drug interaction - 40 seconds ago
- Centrum and Trikafta drug interaction - 45 seconds ago
- Nuvaring and Night Sweats - 47 seconds ago
- Proventil and Ankle Fracture - a minute ago
- Triumeq and Xtandi drug interaction - a minute ago